Abstract
Interleukin 6 (IL-6) is known to play an important role in the biology of the malignant plasma cells in multiple myeloma. In an effort to better understand IL-6 stimulated myeloma cell growth, we have performed gene expression profiling to identify IL-6 early response genes. Using the KAS-6/1 IL-6-dependent human myeloma cell line, IL-6 stimulation dramatically induced expression of monocyte chemoattractant protein-1 (MCP-1) mRNA. To verify this result, we used reverse transcriptase PCR and RNAse protection assays and demonstrated using both assays that MCP-1 is indeed an IL-6 responsive gene in a variety of IL-6-responsive myeloma cell lines. Moreover, we also demonstrated IL-6 stimulated MCP-1 secretion by the myeloma cell lines as well as by fresh patient tumor cells. Lastly, we present evidence that fresh patient tumor cells express mRNA for the MCP-1 receptor, CCR2, as do myeloma cell lines along with a second MCP-1 receptor, CCR11. Although MM cell chemotaxis in response to MCP-1 was only minimal, we were able to demonstrate that MCP-1 stimulated activation of MAPK. Because of the important role that this chemokine plays in both angiogenesis and bone homeostasis, and the ability of MCP-1 to activate myeloma cells, these results suggest a new mechanism by which IL-6 may contribute to disease pathogenesis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Larson RS, Sukpanichnant S, Greer JP, Cousar JB, Collins RD . The spectrum of multiple myeloma: diagnostic and biological implications Hum Pathol 1997 28: 1336–1347
Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L, Dammacco F . Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma Br J Cancer 1999 79: 451–455
Gado K, Domjan G, Hegyesi H, Falus A . Role of interleukin-6 in the pathogenesis of multiple myeloma Cell Biol Intl 2000 24: 195–209
Jelinek DF, Witzig TE, Arendt BK . A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growth J Immunol 1997 159: 487–496
Van Coillie E, Van Damme J, Opdenakker G . The MCP/eotaxin subfamily of CC chemokines Cytok Growth Factor Rev 1999 10: 61–86
Charo IF . CCR2: from cloning to the creation of knockout mice Chem Immunol 1999 72: 30–41
Schweickart VL, Epp A, Raport CJ, Gray PW . CCR11 is a functional receptor for the monocyte chemoattractant protein family of chemokines J Biol Chem 2000 275: 9550–9556
Gerard C, Rollins BJ . Chemokines and disease Nat Immunol 2001 2: 108–115
Salcedo R, Ponce ML, Young HA, Wasserman K, Ward JM, Kleinman HK, Oppenheim JJ, Murphy WJ . Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 2000 96: 34–40
Rahimi P, Wang CY, Stashenko P, Lee SK, Lorenzo JA, Graves DT . Monocyte chemoattractant protein-1 expression and monocyte recruitment in osseous inflammation in the mouse Endocrinology 1995 136: 2752–2759
Graves DT, Jiang Y, Valente AJ . Regulated expression of MCP-1 by osteoblastic cells in vitro and in vivo Histol Histopathol 1999 14: 1347–1354
Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD, Alsina M . Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma Blood 2000 96: 671–675
Nesbit M, Schaider H, Miller TH, Herlyn M . Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells J Immunol 2001 166: 6483–6490
Draube A, Pfister R, Vockerodt M, Schuster S, Kube D, Diehl V, Tesch H . Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH Ann Hematol 2001 80: 83–89
Klouche M, Bhakdi S, Hemmes M, Rose-John S . Novel path to activation of vascular smooth muscle cells: up-regulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor J Immunol 1999 163: 4583–4589
Biswas P, Delfanti F, Bernasconi S, Mengozzi M, Cota M, Polentarutt N, Mantovani A, Lazzarin A, Sozzani S, Poli G . Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line Blood 1998 91: 258–265
De Vos J, Courderc G, Tarte K, Jourdan M, Requirand G, Delteil MC, Rossi JF, Mechti N, Klein B . Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays Blood 2001 98: 771–780
Frade JMR, Mellado M, del Real G, Gutierrez-Ramos JC, Lind P, Martinez-A C . Characterization of the CCR2 chemokine receptor: functional CCR2 receptor expression in B cells J Immunol 1997 159: 5576–5584
Moser B, Loetscher P . Lymphocyte traffic control by chemokines Nat Immunol 2001 2: 123–128
Luther SA, Cyster JG . Chemokines as regulators of T cell differentiation Nat Immunol 2001 2: 102–107
Goede V, Brogelli L, Ziche M, Augustin HG . Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 Int J Cancer 1999 82: 765–770
Ueno T, Toi M, Saji H, Muta M, Bando H, Kuroi K, Koike M, Inadera H, Matsushima K . Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 2000 6: 3282–3289
Acknowledgements
Supported by National Institutes of Health NCI grants CA62242 and CA62228 (DFJ).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arendt, B., Velazquez-Dones, A., Tschumper, R. et al. Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. Leukemia 16, 2142–2147 (2002). https://doi.org/10.1038/sj.leu.2402714
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402714
Keywords
This article is cited by
-
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40
Cancer Gene Therapy (2020)
-
Increased hypothalamic serotonin turnover in inflammation-induced anorexia
BMC Neuroscience (2016)
-
Osteocyte expression of caspase-3, COX-2, IL-6 and sclerostin are spatially and temporally associated following stress fracture initiation
BoneKEy Reports (2014)
-
Hypoxia-inducible factor (HIF)-1α suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction
Leukemia (2013)
-
Extravasation and homing mechanisms in multiple myeloma
Clinical & Experimental Metastasis (2008)